Ellegate, J., Jr.; Mastri, M.; Isenhart, E.; Krolewski, J.J.; Chatta, G.; Kauffman, E.; Moffitt, M.; Eng, K.H.
Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers. Cancers 2022, 14, 731.
https://doi.org/10.3390/cancers14030731
AMA Style
Ellegate J Jr., Mastri M, Isenhart E, Krolewski JJ, Chatta G, Kauffman E, Moffitt M, Eng KH.
Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers. Cancers. 2022; 14(3):731.
https://doi.org/10.3390/cancers14030731
Chicago/Turabian Style
Ellegate, James, Jr., Michalis Mastri, Emily Isenhart, John J. Krolewski, Gurkamal Chatta, Eric Kauffman, Melissa Moffitt, and Kevin H. Eng.
2022. "Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers" Cancers 14, no. 3: 731.
https://doi.org/10.3390/cancers14030731
APA Style
Ellegate, J., Jr., Mastri, M., Isenhart, E., Krolewski, J. J., Chatta, G., Kauffman, E., Moffitt, M., & Eng, K. H.
(2022). Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers. Cancers, 14(3), 731.
https://doi.org/10.3390/cancers14030731